Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Initial Review

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

The meeting announced below concerns Comparison and Validation of Screening Tools for Substance Use Among Pregnant Women, DP15-003, initial review.

SUMMARY:

This document corrects a notice that was published in the Federal Register on March 12, 2015 Volume 80, Number 48, page 13011. The times and dates should read as follows:

Times and Dates: 9:00 a.m.-6:00 p.m., April 7-8, 2015 (Closed).

Start Further Info

FOR FURTHER INFORMATION CONTACT:

M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, Georgia 30341, Telephone: (770)488-3585, EEO6@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Claudette Grant,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Further Info End Preamble

[FR Doc. 2015-08519 Filed 4-13-15; 8:45 am]

BILLING CODE 4163-18-P